Abstract
Common colds are among the mildest of diseases affecting man, but they are also very frequent. Indeed, adults are said to have from 2 to 5 episodes a year on the average and certain predisposed children may have 12 attacks a year. The disease is often sufficiently severe to cause absence from work or education. In predisposed patients the colds may go on to bronchitis or may precipitate heart failure or upset the control of diabetes.
Chapter PDF
Similar content being viewed by others
Keywords
- Respiratory Syncytial Viral Infection
- Common Cold
- Respiratory Epithelium
- Nasal Secretion
- Tracheal Epithelium
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
GWALTNEY, J. M. (1957) Rhinoviruses. Yale J. Biol. Med. 108, 444–453
LARSON, H. E,, REED, S. E., and TYRRELL, D. A. J. (1980) Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J. med. Virol., 5, 221–229
MACNAUGHTON, M. R. (1982) The structure and replication of rhinoviruses, Current Topics in Microbiology and Immunology 21, 1–26
GREENBERG, S. B., HARMON, M. W., TYRRELL, D. A. J. and SCOTT, G. M. (1981–82) Trials of interferon in respiratory infections in man. Texas Rep. Biol. Med. 51, 549–553
HILL, D. A., BARON, S., PERKINS, J. C., WORTHINGTON, M., VAN KIRK, J. E., MILLS, J., KAPIKIAN, A. Z., CHANOCK, R. M. (1972) Evaluation of an interferon inducer in viral respiratory disease. J. Amer. Med. Assoc. 219, 1179–1184
AOKI, F. Y., REED, S. E., CRAIG, J. W., TYRRELL, D. A. J. and LEES, L. J. (1958) Effect of a polynucleotide inducer of fungal origin on experimental rhinovirus infection in humans. J. Infect. Dis. 11, 82–86
DOUGLAS, R. G. and BETTS, R. F. (1974) Effect of induced interferon in experimental rhinovirus infections in volunteers. Infect. Immun. 2, 506–510
STANLEY, E. D., JACKSON, G. G., DIRDA, V. A. and RUBENIS, M. (1976) Effect of a topical interferon inducer on rhinovirus infections in volunteers. J. Infect. Dis. (Supp/June 1976 ) 121–127
ACORNLEY, J. E., BESSELL, C. J., BYNOE, M. L., GOTFREDSEN, W. O. and KNOYLE, J. M. (1967) Antiviral activity of sodium fusidate and related compounds. Brit. J. Pharmacol. Chemother. 11, 210–220
MATHUR, A., BEARE, A. S. and REED, S. E. (1973) In vitro activity and preliminary clinical trials of a new adamantane compound. Antimicrob. Agents Chemother. 4, 421–426
REED, S. E. and BYNOE, M. L. (1970) The antiviral activity of isoquinoline drugs for rhinoviruses in vitro and in vivo. J. med. Microbiol. 21, 346–352
TOGO, Y., SCHWARTZ, A. R. and HORNICK, R. B. (1973) Antiviral effect of 3,4-dihydro-l-isoquinoline acetamide hydrochloride in experimental human rhinovirus infection. Chemotherapy. 18, 17
SOTO, A. J., HALL, T. S. and REED, S. E. (1973) Trial of the antiviral action of isoprinosine against rhinovirus infection of volunteers. Antimicrobial Agents Chemother. 2, 332–334
ANON (1982) Inosiplex: Antiviral, immunomodulator, or neither? Lancet 1, 1052–1054
TAMM, I., CALIGUIRI, L. A. (1972) 2-(oC-hydroxybenzyl) benzimidazole and related compounds in: Chemotherapy of virus diseases I. Ed. D. J. BAUER 115–180
KORANT, B. D., BAUER, J. C., BUTTERWORTH, B. E. (1974) Zinc ions inhibit replication of rhinoviruses. Nature 248, 558–560
BEARE, A. S., and REED, S. E. (1977) The study of antiviral compounds in volunteers in: Chemoprophylaxis and virus infection of the respiratory tract. Vol II Ed J. Oxford C.R.C. Press, Cleveland, Ohio p27–55
PINTO, C. A., BARN SEN, H. P., RAVIN, L. J., HAFF, R. F. and PAGANO, J. E. (1972) The antiviral effect of a triazinoindole (SKand F 40491) in rhinovirus infected gibbons. Proc. Soc. exp. Biol. Med. 141, 467–74
TOGO, Y., SCHWARTZ, A. R. and HORNICK, R. B. (1973) Failure of a 3-substituted triazoinoinsole in the prevention of experimental human rhinovirus infection. Chemotherapy, 18, 17–26
REED, S. E., CRAIG, J. W. and TYRRELL, D. A. J. (1976) Four compounds active against rhinovirus: comparison in vitro and in volunteers. J. Infect. Dis. (Suppl) 138:Al28-A135
DELONG, D. C. and REED, S. E. (1980) Inhibition of rhinovirus replication in organ culture by a potential antiviral drug. J. infect. Dis. 141, 87–91
PHILLPOTTS, R. J., JONES, R. W., DELONG, D. C., REED, S. E., WALLACE, J. and TYRRELL, D. A. J. (1981) The activity of enviroxime against rhinovirus infection in man. Lancet 11, 1342–1344
HAYDEN, F. G. and GWALTNEY, J. M. Jr (1982) Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection. Antimicrob. Agents Chemother. 21, 892–897
LEVANDOWSKI, R. A., PACHUCKI, C. T., RUBENIS, M. and JACKSON, G. G. (1983) Topical enviroxime against rhinovirus infection. Antimicrob. Agents Chemother. 22, 1004–7
PHILLPOTTS, R. J., WALLACE, J., TYRRELL, D. A. J. and TAGART, V. B. (1983) A study of the therapeutic activity of enviroximeagainst rhinovirus infection in volunteers. Antimicrob. Agents Chemother. 21: 671–675
BAUER, D. J., SELWAY, J. W. T., BATCHELOR, J. F., TISDALE, MARGARET, CALDWELL, IAN C. and YOUNGS D. A. B. (1981) 4’, 6-Dichloroflavan (BW683c) a new antirhinovirus compound. Nature 222 (5821) 369–70
PHIT,T,P0TTS, R. J., WALLACE, J. W., TYRRELL, D. A. J., FREESTONE, D. and SHEPHERD, W. N. (1983) Failure of oral 4, 6, dichloroflavan to protect against rhinovirus infection in man. Arch. Virol., 1: 15–21
ITHITSUKA, H., NINOMIYA, Y. T., OHSANA, C., FIJIU, M. and SUBARA, Y. (1982) Direct and specific inactivation of rhinovirus by chalcone Ro 09–0410 Antimicrob. Agents Chemother. 22, 617–21
PHILLPOTTS, R. J., HIGGINS, P. G., WILLMAN, J., TYRRELL, D. A. J., LENNOX-SMITH, I. (1983) Evaluation of the antirhinovirus chalcone Ro 09–0410 in volunteers. Manuscript in preparation.
HALL, C. B., McBRIDÉ, J. T., WALSH, E. E., BELL, D. M„ GALA, C. L., HILDRETH, S., TEN EYCK. L. G. and HALL, W. J. (1983) Aerosolized ribavirin treatment with respiratory syncytial viral infection. New Eng. J. Med. 8, 1443–1447
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tyrrell, D.A.J. (1984). Antirhinovirus Drugs. In: De Clercq, E., Walker, R.T. (eds) Targets for the Design of Antiviral Agents. NATO ASI Series, vol 73. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4709-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4709-5_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4711-8
Online ISBN: 978-1-4684-4709-5
eBook Packages: Springer Book Archive